Neogenomics Inc
NEO- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- SEC CIK
- 0001077183
In the last 90 days, Neogenomics Inc insiders filed 0 open-market purchases and 1 sale; 275 institutions reported holding it in 13F filings for Q2 2026, worth $2.18B in total; Oaktree Capital is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Neogenomics Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $321.4K in total
- Insiders trading
- 1
- Net value
- −$321.4K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Neogenomics Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Olivo Alicia C | EVP, GC & Business Development | 90,875 | Sep 3, 2026 | 8 |
| Stone Warren | Pres & Chief Operating Officer | 181,078 | Aug 25, 2026 | 9 |
| Aunan Greg D | Chief Accounting Officer | 5,153 | Aug 6, 2026 | 4 |
| Starrett Carolyn S | Director | – | Jun 25, 2026 | 1 |
| Tetrault Lynn A. | Director | 86,115 | Jun 17, 2026 | 3 |
| Williams Felicia | Director | 30,237 | Jun 3, 2026 | 1 |
| Kanovsky Stephen M | Director | 75,421 | Jun 3, 2026 | 1 |
| Kenny John P. | Director | 5,893 | Jun 3, 2026 | 2 |
| Perez David Brian | Director | 56,967 | Jun 3, 2026 | 1 |
| Kelly Michael Aaron | Director | 67,086 | Jun 3, 2026 | 1 |
| Gunn Neil | Director | 51,177 | Jun 3, 2026 | 1 |
| Green Marjorie C | Director | 22,964 | Jun 3, 2026 | 1 |
| Zook Anthony P. | Chief Executive Officer | 133,111 | Apr 3, 2026 | 2 |
| Sherman Jeffrey Scott | Chief Financial Officer | 220,009 | Feb 24, 2026 | 2 |
| Hannah Alison L. | Director | 131,023 | Jun 3, 2025 | 0 |
| Floegel Elizabeth | Director | 23,590 | Jun 3, 2025 | 0 |
| Smith Christopher M | Chief Executive Officer | 641,585 | Feb 25, 2025 | 0 |
| Harris Melody | Chf Ops Off, Pres, Informatics | 109,755 | Feb 25, 2025 | 0 |
| Sikri Vishal | President Advanced Diagnostics | 127,716 | Feb 27, 2024 | 0 |
| Crowther Bruce K | Director | 65,120 | Aug 14, 2023 | 0 |
| Kulkarni Shashikant | Chief Scientific Officer | 82,673 | Apr 4, 2023 | 0 |
| Dieter Cynthia J | Chief Accounting Officer | 29,765 | Mar 3, 2023 | 0 |
| Sholehvar David | President, Clinical Services | 43,216 | Aug 3, 2022 | 0 |
| Daly David | Director | 17,179 | Jun 14, 2022 | 0 |
| Stahler Rachel A | Director | 21,335 | Jun 14, 2022 | 0 |
| Bonello William | Chief Financial Officer | 191,548 | May 2, 2022 | 0 |
| Brown Douglas Matthew | Chief Strategy Officer | 158,684 | Apr 4, 2022 | 0 |
| Cardoza George | President & COO, Lab Ops | 244,157 | Mar 3, 2022 | 0 |
| Gilbert Halley E | Chief Legal Officer | 147,396 | Mar 3, 2022 | 0 |
| Mallon Mark | Chief Executive Officer | 368,051 | Mar 3, 2022 | 0 |
| Wallar Gina M | President, Pharma Services | 33,443 | Mar 3, 2022 | 0 |
| McKenzie Kathryn B | Chief Sustainability/Risk Ofcr | 49,361 | Jan 12, 2022 | 0 |
| Balliet Jennifer | VP and Chief Culture Officer | 48,615 | Dec 30, 2021 | 0 |
| Morris Clive | President of Inivata | 41,280 | Dec 30, 2021 | 0 |
| Johnson Kevin C | Director | 37,398 | Dec 23, 2021 | 0 |
| Van Oort Douglas M | Director | 2,468,797 | Aug 13, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 (view filing)4:02 PM ET | Aug 4 | 2 days | Aunan Greg DChief Accounting Officer | SSale | −20.0K | $16.07 | −$321.4K | −79.5%5.15K after | |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Tetrault Lynn A.Director | SSale | −5.31K | $11.10 | −$58.9K | −5.8%86.1K after | 10b5-1 |
| Jun 11, 2026 (view filing) | Jun 9 | 2 days | Tetrault Lynn A.Director | SSale | −5.31K | $11.29 | −$59.9K | −5.5%91.4K after | 10b5-1 |
| Jan 21, 2026 (view filing) | Jan 20 | 1 day | Stone WarrenPres & Chief Operating Officer | SSale | −22.1K | $12.50 | −$276.6K | −15.4%121.6K after | 10b5-1 |
| Nov 28, 2025 (view filing) | Nov 25 | 3 days | Olivo Alicia CEVP, GC & Business Development | SSale | −20.9K | $12.00 | −$251.0K | −40.2%31.1K after | 10b5-1 |
| Oct 20, 2025 (view filing) | Oct 16 | 4 days | Olivo Alicia CEVP, GC & Business Development | SSale | −4.92K | $10.00 | −$49.2K | −10.3%43.0K after | 10b5-1 |
| Aug 6, 2025 (view filing) | Aug 6 | Same day | Sherman Jeffrey ScottChief Financial Officer | PPurchase | +20.0K | $5.62 | +$112.4K | +11.9%188.3K after | |
| Aug 6, 2025 (view filing) | Aug 6 | Same day | Zook Anthony P.Chief Executive Officer | PPurchase | +17.9K | $5.58 | +$99.9K | +88.8%38.1K after | |
| May 28, 2025 (view filing) | May 27 | 1 day | Kelly Michael AaronDirector | PPurchase | +5.00K | $7.60 | +$38.0K | New position5.00K after | |
| May 13, 2025 (view filing) | May 12 | 1 day | Stone WarrenPres & Chief Operating Officer | PPurchase | +5.70K | $8.58 | +$48.9K | +5.6%108.3K after | |
| May 9, 2025 (view filing) | May 9 | Same day | Tetrault Lynn A.Director | PPurchase | +7.00K | $8.14 | +$57.0K | New position7.00K after | |
| May 9, 2025 (view filing) | May 7 | 2 days | Kanovsky Stephen MDirector | PPurchase | +4.00K | $7.78 | +$31.1K | +11.1%40.1K after | |
| May 8, 2025 (view filing) | May 6 | 2 days | Zook Anthony P.Chief Executive Officer | PPurchase | +18.9K | $7.88 | +$148.9K | New position18.9K after | |
| May 7, 2025 (view filing) | May 5 | 2 days | Perez David BrianDirector | PPurchase | +10.0K | $7.63 | +$76.3K | New position10.0K after | |
| May 7, 2025 (view filing) | May 5 | 2 days | Gunn NeilDirector | PPurchase | +4.51K | $7.76 | +$35.0K | +39.8%15.8K after | |
| May 6, 2025 (view filing) | May 2 | 4 days | Sherman Jeffrey ScottChief Financial Officer | PPurchase | +20.0K | $7.51 | +$150.2K | +14.4%158.5K after | |
| Nov 19, 2024 (view filing) | Nov 15 | 4 days | Olivo Alicia CGeneral Counsel | SSale | −5.17K | $15.36 | −$79.5K | −12.2%37.1K after | 10b5-1 |
| Aug 19, 2024 (view filing) | Aug 15 | 4 days | Olivo Alicia CGeneral Counsel | SSale | −1.04K | $16.05 | −$16.7K | −2.3%43.8K after | 10b5-1 |
| May 17, 2024 (view filing) | May 15 | 2 days | Olivo Alicia CGeneral Counsel | SSale | −1.05K | $15.74 | −$16.5K | −2.3%44.9K after | 10b5-1 |
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Tetrault Lynn A.Director | SSale | −6.11K | $15.97 | −$97.6K | −10.9%50.1K after | 10b5-1 |
| Feb 20, 2024 (view filing) | Feb 15 | 5 days | Olivo Alicia CGeneral Counsel | SSale | −2.59K | $14.96 | −$38.7K | −6.9%34.9K after | 10b5-1 |
| Nov 20, 2023 (view filing) | Nov 17 | 3 days | Olivo Alicia CGeneral Counsel | SSale | −2.67K | $18.39 | −$49.1K | −6.7%37.1K after | 10b5-1 |
| Mar 9, 2022 (view filing) | Mar 7 | 2 days | Bonello WilliamChief Financial Officer | SSale | −3.21K | $18.29 | −$58.7K | −3.2%98.5K after | |
| Dec 23, 2021 (view filing) | Dec 21 | 2 days | McKenzie Kathryn BChief Financial Officer | SSale | −1.85K | $35.00 | −$64.6K | −13.6%11.7K after | |
| Dec 6, 2021 (view filing) | Dec 6 | Same day | Mallon MarkChief Executive Officer | PPurchase | +17.0K | $30.63 | +$520.7K | +30.5%72.7K after | |
| Nov 29, 2021 (view filing) | Nov 24 | 5 days | Bonello WilliamPresident, Informatics | SSale | −25.0K | $37.13 | −$928.3K | −61.8%15.5K after | |
| Nov 26, 2021 (view filing) | Nov 23-26 | 3 days | Brown Douglas MatthewChief Strategy Officer | SSale | −100.0K | $36.96 | −$3.70M | −89.6%11.6K after | 3 lots |